World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
66
Citations
13080
World Ranking
2439
National Ranking
988

Overview

Jeffrey S. Glenn is affiliated with Stanford University in the United States and has a research focus primarily in the field of Medicine. Their work spans several subfields including Epidemiology, Infectious Diseases, Hepatology, Molecular Biology, and Immunology.

The scientist's research covers a number of main topics, notably:

  • Hepatitis C virus research
  • Hepatitis B Virus Studies
  • Liver Disease Diagnosis and Treatment
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • RNA and protein synthesis mechanisms
  • Bacteriophages and microbial interactions

A selection of recent papers authored or co-authored by this researcher includes:

  • A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures (2020), published in Nature
  • Progenitor identification and SARS-CoV-2 infection in human distal lung organoids (2020), published in Nature
  • Structure of the neurotensin receptor 1 in complex with β-arrestin 1 (2020), published in Nature
  • Extracellular cGAMP is a cancer-cell-produced immunotransmitter involved in radiation-induced anticancer immunity (2020), published in Nature Cancer
  • RNA genome conservation and secondary structure in SARS-CoV-2 and SARS-related viruses: a first look (2020), published in RNA

Frequent collaborators in their research include:

  • Ingrid Choong
  • Ralph S. Baric
  • Ohad Etzion
  • Colin Hislop
  • Saeed Hamid

The venues where Jeffrey S. Glenn has most frequently published are:

  • Journal of Hepatology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature
  • Hepatology
  • UNC Libraries

Best Publications

  • A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures.

    Kenneth H. Dinnon;Sarah R. Leist;Alexandra Schäfer;Caitlin E. Edwards

  • Identification of a prenylation site in delta virus large antigen

    Jeffrey S. Glenn;John A. Watson;Christopher M. Havel;Judith M. White

  • Structural Linkage between Ligand Discrimination and Receptor Activation by Type I Interferons

    Christoph Thomas;Ignacio Moraga;Doron Levin;Peter O. Krutzik

  • Structure of the neurotensin receptor 1 in complex with β-arrestin 1.

    Weijiao Huang;Matthieu Masureel;Qianhui Qu;John Janetzko

  • Progenitor identification and SARS-CoV-2 infection in human distal lung organoids.

    Ameen A. Salahudeen;Ameen A. Salahudeen;Shannon S. Choi;Arjun Rustagi;Junjie Zhu

  • Extracellular cGAMP is a cancer cell-produced immunotransmitter involved in radiation-induced anti-cancer immunity.

    Jacqueline A. Carozza;Volker Böhnert;Khanh C. Nguyen;Gemini Skariah

  • Six RNA Viruses and Forty-One Hosts: Viral Small RNAs and Modulation of Small RNA Repertoires in Vertebrate and Invertebrate Systems

    Poornima Parameswaran;Ella Sklan;Courtney Wilkins;Trever Burgon

  • Discovery of a hepatitis C target and its pharmacological inhibitors by microfluidic affinity analysis

    Shirit Einav;Doron Gerber;Paul D Bryson;Ella H Sklan

  • Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial.

    Christopher Koh;Laetitia Canini;Laetitia Canini;Harel Dahari;Harel Dahari;Xiongce Zhao

  • RNA genome conservation and secondary structure in SARS-CoV-2 and SARS-related viruses: a first look.

    Ramya Rangan;Ivan N. Zheludev;Rachel J. Hagey;Edward A. Pham

  • An N-Terminal Amphipathic Helix in Hepatitis C Virus (HCV) NS4B Mediates Membrane Association, Correct Localization of Replication Complex Proteins, and HCV RNA Replication

    Menashe Elazar;Ping Liu;Ping Liu;Charles M. Rice;Jeffrey S. Glenn;Jeffrey S. Glenn

  • In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus.

    Bruno B. Bordier;Junko Ohkanda;Ping Liu;Ping Liu;So Young Lee

  • Amphipathic Helix-Dependent Localization of NS5A Mediates Hepatitis C Virus RNA Replication

    Menashe Elazar;Kwang Ho Cheong;Kwang Ho Cheong;Ping Liu;Harry B. Greenberg;Harry B. Greenberg

  • Early Treatment with Pegylated Interferon Lambda for Covid-19

    Unknown

  • Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial.

    Jordan J Feld;Jordan J Feld;Christopher Kandel;Mia J Biondi;Mia J Biondi;Robert A Kozak

  • COVID-19 and emerging viral infections: The case for interferon lambda.

    Ludmila Prokunina-Olsson;Noémie Alphonse;Noémie Alphonse;Ruth E. Dickenson;Joan E. Durbin

  • Sustained survival of human hepatocytes in mice: A model for in vivo infection with human hepatitis B and hepatitis delta viruses

    Kazuo Ohashi;Patricia L. Marion;Hiroyuki Nakai;Leonard Meuse

  • Changing Trends in Etiology-Based Annual Mortality From Chronic Liver Disease, From 2007 Through 2016.

    Donghee Kim;Andrew A. Li;Chiranjeevi Gadiparthi;Muhammad Ali Khan

  • A Nucleotide Binding Motif in Hepatitis C Virus (HCV) NS4B Mediates HCV RNA Replication

    Shirit Einav;Menashe Elazar;Tsafi Danieli;Jeffrey S. Glenn;Jeffrey S. Glenn

  • Changing Trends in Etiology-Based and Ethnicity-Based Annual Mortality Rates of Cirrhosis and Hepatocellular Carcinoma in the United States

    Donghee Kim;Andrew A. Li;Brandon J. Perumpail;Chiranjeevi Gadiparthi

  • Parallel shRNA and CRISPR-Cas9 screens enable antiviral drug target identification

    Richard M Deans;David W Morgens;Ayşe Ökesli;Sirika Pillay

Frequent Co-Authors

Nam-Joon Cho
Nam-Joon Cho Nanyang Technological University
Theo Heller
Theo Heller National Institutes of Health
Curtis W. Frank
Curtis W. Frank Stanford University
Mark A. Winters
Mark A. Winters Stanford University
Charles M. Rice
Charles M. Rice Rockefeller University
Harry B. Greenberg
Harry B. Greenberg Stanford University
Ralph S. Baric
Ralph S. Baric University of North Carolina at Chapel Hill
Robert G. Gish
Robert G. Gish University of Nevada Reno
David E. Kleiner
David E. Kleiner National Institutes of Health
Mark A. Kay
Mark A. Kay Stanford University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying microbiology in the USA opens doors to diverse career pathways, some of which intersect with health information and medical coding fields. For individuals interested in the administrative and data-focused side of healthcare, pursuing a certified professional coder (cpc) credential can lead to rewarding roles that support clinical documentation and billing accuracy.

Those looking to expand their scope might consider obtaining a health information management bachelor degree salary, which reflects the growing demand and competitive wages in this sector. This degree equips graduates to manage healthcare data, improving patient care and regulatory compliance.

For flexibility and quality assurance, exploring an online cahiim accredited health information management degree can be an ideal option. These accredited programs ensure that students receive comprehensive training recognized by industry standards.

Additionally, accelerated pathways such as a medical billing and coding certificate online accelerated program offer a quick entry into the workforce, perfect for those seeking to complement their microbiology expertise with valuable technical skills in healthcare administration.

Best Scientists Citing Jeffrey S. Glenn

Trending Scientists

Recently Published Articles